Investigator: Ji Qiu, Ph.D., Garrick Wallstrom, Ph.D. and Gokhan Demirkan, Ph.D.
Collaborators: Noralane M. Lindor, M.D. (Mayo Clinic)
|Who gets it?
What are the symptoms?
|How do we detect it now?
How is it currently treated?
|What are the current challenges?|
Similar to many of our other projects that use NAPPA to discover autoantibodies to detect disease, this project also relies on evidence that specific biomarkers for colorectal cancer exist. We are working to identify markers in the blood that would provide a simple blood test to detect a high risk of colorectal cancer, identifying those patients who are at a greater need of further diagnostic testing.